Eagle Health Investments LP

CIK 0001842545 · GREENWICH, CT · Quarter end: 2026-06-30 · Filed on: 2026-08-10 · Open the SEC source

Eagle Health Investments LP reported 27 positions worth $603.3M as of June 30, 2026 (13F filed August 10, 2026). Largest holding: ARGX (11.8%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$603.3M
2026 Q2
Positions
27
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
66.1%
Est. Net Flow (Q)
2026 Q2
10 / 27 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1ARGXARGENX SESH$70.9M11.75%76,417
2ICLRICON PUB LTD COSH$53.5M8.87%308,143
3GHGUARDANT HEALTH INCSH$45.1M7.48%300,685
4INSMINSMED INCSH$41.0M6.79%384,130
5BMRNBIOMARIN PHARMACEUTICAL INCSH$35.7M5.92%624,676
6ILMNILLUMINA INCSH$33.0M5.46%187,413
7SRRKSCHOLAR ROCK HLDG CORPSH$30.5M5.06%555,272
8PTGXPROTAGONIST THERAPEUTICS INCSH$30.4M5.04%248,322
9RAREULTRAGENYX PHARMACEUTICAL INSH$29.5M4.89%884,121
10CMPSCOMPASS PATHWAYS PLCSH$29.2M4.83%2,060,427

The free plan shows the top 10 positions. The remaining 17 positions, the full portfolio and quarter changes unlock with Pro.

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does Eagle Health Investments LP hold as of Q2 2026?

Eagle Health Investments LP reported 27 positions worth $603.3M in its Q2 2026 13F filing. Largest positions: ARGX (11.8%), ICLR (8.9%), GH (7.5%), INSM (6.8%) and BMRN (5.9%).

What did Eagle Health Investments LP buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Eagle Health Investments LP sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.